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S econdary lymphedema is a chronic swelling of a limb that develops following lymph node dissec-
tion or radiation therapy for conditions such as an 
intrapelvic tumor,  breast cancer,  and melanoma.  
Major limb swelling reduces motor function,  and the 
frequent occurrence of cellulitis leads to lowered activi-
ties of daily living (ADLs) in cancer survivors.  
Lymphedema is an abnormal congestion of the lym-
phatic system due to decreased lymphatic function.  The 
pathophysiology of lymphedema is complex and not yet 
established [1–6].  The reason for this insufficient 
understanding of secondary lymphedema is a lack of 
anatomical information of the lymphatic system,  espe-
cially the abnormal lymphatic system in lymphedema 
patients.  Difficulties in live imaging of the lymphatic 
system also remain.
Therefore,  in recent years,  various methods for 
mapping the lymphatic vessels have been developed.  
There are pros and cons to all of these methods,  and 
there is no established technique that visualizes thin and 
transparent lymphatic vessels in the living body.  Several 
mapping methods are in use for lymphatic vessels in 
clinical settings.  
In the direct contrast method,  cannulation is 
directly performed on lymphatic vessels under micros-
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As a new trial,  we used interstitial computed tomography-lymphography (CT-LG) in 10 patients with lower 
extremity lymphedema (n = 20 limbs) at stage 0,  1,  2,  or 3 under the International Society of Lymphology (ISL) 
classification.  In all cases,  CT-LG,  lymphoscintigraphy,  and indocyanine green fluorescence-lymphography 
(ICG-LG) were performed.  In the examination of the ascending level of depicted lymphatic vessels,  we mea-
sured the diameters of lymphatic vessels detected with CT-LG and conducted an image analysis of dermal back-
flow of lymph (DB).  CT-LG had better resolution than lymphoscintigraphy and enabled the clear visualization 
of lymphatic vessels with a minimum lumen size of 0.7 mm.  CT-LG also showed the three-dimensional archi-
tecture of the DB,  which originated from deep lymphatic collectors via branched small lymphatic vessels.  Our 
findings are quite valuable not only for detailed examinations of lymphedematous sites and for the lymphedema 
surgery,  but also for investigations of the pathogenesis of lymphedema which has not yet been established.  We 
observed that lymphoscintigraphy could show the lymphatic vessels up to the thigh level in all cases,  whereas 
CT-LG enabled the vessels’ visualization up to the leg level at maximum.  In conclusion,  CT-LG provided ade-
quate and detailed three-dimensional imaging of the lymphatic system in lymphedema patients.
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copy,  and a contrast agent is injected.  This method has 
been used since the 1950s [7],  but it is invasive and 
there is a high risk of retention of contrast agent and 
possibly a pulmonary embolism; thus,  the direct con-
trast method is not used frequently now.
The indirect contrast method,  in which the contrast 
agent is subcutaneously or intradermally injected and 
then physiologically taken up by lymphatic vessels,  is 
being developed in various ways because of its low inva-
siveness.  Since 1953,  lymphoscintigraphy has been 
used as the gold standard [8] for lymphatic examina-
tions.  Lymphoscintigraphy is less invasive and is able to 
capture the overall image of the lymphatic drainage 
pattern,  but its weakness is the low definition of the 
resultant images.  As lymphoscintigraphy requires a 
scintillation camera,  there is also an issue with radia-
tion exposure.
Indocyanine green fluorescence lymphography 
(ICG-LG) has become widespread since 2006 [9],  when 
the near-infrared observation camera became commer-
cially available.  ICG-LG enables very detailed analyses 
of the network of lymphatic vessels without providing 
radiation exposure,  and it makes dynamic observations 
possible.  However,  there are disadvantages of ICG-LG 
examinations as well,  such as difficulty observing 
depths of ≥ 15 mm and difficulty in capturing the entire 
image.
MRI lymphography (MRL-LG) is a technique 
reported by Dimakakos et al.  in 2007 [10].  Relatively 
high-definition images can be obtained without radia-
tion exposure,  but an MRL-LG examination requires 
approx.  an hour of imaging time,  meaning the image 
can easily become blurred.  In addition,  the contrast 
agent used for MRI can easily enter the venous circula-
tion [11].
Computed tomography lymphography (CT-LG) was 
first reported by Suga et al.  in 2003 [12].  Extremely 
high-definition images can be obtained,  and the exam-
ination takes only about 5 min.  Images can be obtained 
within a short time,  and the imaging devices are rela-
tively widely distributed.  The main disadvantage of 
CT-LG is the radiation exposure.
We used the interstitial CT-LG method described by 
Suga et al.  [13-15] to three-dimensionally and compre-
hensively observe the lymphatic vessels of the extremi-
ties in high definition using multi detector-row CT 
(MDCT).  We used the gold standard (i.e.,  lymphoscin-
tigraphy) and ICG-LG,  both of which are now wide-
spread,  on the same patients,  and we compared the 
utility of CT-LG in lymphedema.  This study is the first 
report regarding the use of CT-LG on extremities of 
lymphedema patients.
Patients and Methods
Patient enrollment and physical examinations.
The study subjects were 10 patients with lower extrem-
ity lymphedema (20 limbs) who underwent CT-LG,  
lymphoscintigraphy,  and ICG-LG between November 
2013 and August 2015 at Okayama University Hospital.  
Seven patients had secondary lymphedema (14 limbs),  
and 3 had primary lymphedema (6 limbs) (Table 1).
A blood test and chest X-ray examination were per-
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Table 2　 ISL staging of lymphedema
ISL stage Features
0 A subclinical state. No oedema but presence of lymphatic impairment.
1 Mild oedema that is reversible with appropriate limb elevation.
2 Moderate oedema that is not reversible with limb elevation. 
Pitting present, except in late stage 2 when more ﬁbrosis occurs.
3 Lymphostatic elephantiasis with trophic skin changes such as acanthosis, deposition of fat and ﬁbrosis, warty overgrowth.
Sources: [19 ,20]
Table 1　 Patient characteristics
age-years mean±SD 50±16
primary or secondray-no./total no. (%)
primary 6/20 (30)
secondry 14/20 (70)
sex-no./total no (%)
male 2/20 (10)
female 18/20 (90)
ISL stages-no./total no. (%)
stage 0 5/20 (25)
stage 1 3/20 (15)
early stage 2 5/20 (25)
late stage 2 5/20 (25)
stage 3 2/20 (10)
SD = standard deviation
formed during the first examination,  and patients with 
diseases other than lymphedema and those who were 
suspected of causing lower extremity edema were 
excluded.  Two experienced lymphedema therapists 
recorded the patients’ physical findings and symptoms,  
and edema stages were determined according to the 
International Society of Lymphology lymphedema stage 
classification (Table 2).
All studies were performed under the approval of the 
Ethics Committee of Okayama University Hospital 
(ethics No. 1052).  In addition,  after being provided 
with sufficient explanation,  all patients provided 
informed consent to undergo the examinations and have 
their results published.
CT-LG. MDCT-LG was performed as described 
by Suga et al.  [12] in 2003 to identify sentinel lymph 
nodes in breast cancer.  An MDCT scanner (Aquilion 
TSX-101A; Toshiba Medical Systems,  Tochigi,  Japan) 
was used in this study.  A total of 0.8 ml of 1% Xylocaine® 
(AstraZeneca,  Osaka,  Japan) was injected subcutane-
ously into the 1st to 4th interdigital web space of the 
dorsum of the foot,  using a 30-gauge needle to reduce 
the pain.  A total of 4 ml of Iopamidol (Iopamiron 
370; Bayer Yakuhin,  Osaka,  Japan) was then equally 
injected intradermally using a 24-gauge needle at the 
exact same locations.  After the iopamidol was adminis-
tered,  the injection sites ware massaged gently for 
10 min to facilitate the migration of the contrast agent to 
draining lymphatics.  Thirty min after the administra-
tion of iopamidol,  contiguous 1-mm-thick CT images 
were acquired from tip of the foot to the groin area.  The 
CT scanning was operated at 120 kV and 250 mA,  with 
a 50-cm field of view and a 512 × 512 matrix.  Three-
dimensional CT images were then reconstructed using 
maximum intensity projection (MIP) and surface ren-
dering techniques at a medical imaging analysis work 
station (AZE Virtual Place; AZE Corp.,  Tokyo,  Japan).
Lymphoscintigraphy. The lymphoscintigraphic 
studies were performed by subcutaneously injecting 
185 MBq 99mTc-DTPA-HSA (Techne®Albumin kit,  
FujiFilm RI Pharma,  Tokyo,  Japan),  divided in the 1st 
and 4th interdigital web spaces.  A total of 0.2 ml of the 
tracer was injected with a 27-gauge needle.  
Subsequently,  the injected areas were massaged for 
5 min and entire- body images were taken with a scinti-
camera (GE Discovery NM/CT670,  GE Healthcare 
Japan,  Tokyo,  Japan) 5 and 30 min after the injection of 
the radioactive tracer [16].
ICG-LG. For the ICG-LG,  25 mg of ICG 
(DIAGNO-GREEN®,  Daiichi-Sankyo,  Tokyo) was dis-
solved in 2 ml of distilled water,  and 2 ml of 1% 
Xylocaine® (AstraZeneca,  Osaka,  Japan) was added to 
reduce pain.  A total of 0.2 ml of the solution was sub-
cutaneously injected into the 1st and 4th interdigital 
web spaces.  Subsequently,  the patient was asked to walk 
for 30 min,  and the lymphatic vessels were recorded 
with a Photo Dynamic Eye® (Hamamatsu Photonics,  
Shizuoka,  Japan).  Still images were captured from the 
video record [17].
Analysis of examination protocols and comparison 
of results. First,  we evaluated the examination pro-
tocols.  For the total of 20 limbs,  we used early-stage 
lymphedema (stage 0,  5 limbs; stage 1,  3 limbs; early 
stage 2,  5 limbs) to determine the depiction rate of each 
part where lymphatic vessels were successfully imaged.  
We divided the depiction level in 4 groups: (1) static,  
(2) up to the dorsum of the foot,  (3) up to the leg,  and 
(4) up to the thigh.  The results of lymphoscintigraphy,  
classified into the same 4 groups,  were compared for the 
same limb.  Then,  for the 20 limbs,  the diameters of 
45 lymphatic vessels detected with CT-LG were mea-
sured in a perpendicular slice of lymphatic vessel,  and 
the mean,  minimum,  and maximum values were cal-
culated.  The diameter was measured at the thinnest part 
of each lymphatic vessel detected.
Last,  we performed an image analysis of the dermal 
backflow of lymph (DB) detected with CT-LG and per-
formed an anatomic evaluation.
Results
Examination of the test protocols. The limbs 
with early-stage lymphedema (stages 0‒early stage 2) 
were imaged well with lymphoscintigraphy,  up to the 
thigh.  However,  when the same group was imaged with 
the present CT-LG protocol,  the visualization of the 
transport of the contrast agent to the thigh was clearly 
poorer,  including the following results: one limb with 
no movement from the injection site,  2 limbs that were 
imaged up to the dorsum of the foot,  10 limbs that were 
imaged up to the leg,  and no limbs that were imaged up 
to the thigh level (Fig. 1).
The dose of the contrast agent for the CT-LG and 
that for the lymphoscintigraphy was 4 and 0.2 ml,  
respectively.  A total of 4 injection sites were required 
for CT-LG (2nd and 3rd interdigital web spaces,  in 
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addition to the 1st and 4th used for lymphoscintigra-
phy).  The final observation time was 30 min for both 
CT-LG and lymphoscintigraphy.
Anatomical evaluation of visualization of lym-
phatic vessels and DB with CT-LG. Our results 
demonstrated that CT-LG could depict the collecting 
lymphatic vessels,  traveling in the deep layer to the 
superficial fascia in a tortuous manner,  ascending 
toward the proximal part,  and diverging to the several 
small lymphatics.
The mean and minimum diameters of the lumen of 
the lymphatic vessels imaged by CT-LG (n = 45) were 
1.2 and 0.7 mm,  respectively (Figs. 2 , 3).  By CT-LG,  
the DB was imaged as an aggregation of high contrast at 
the dermal area,  but unlike ICG-LG,  DB types could 
not be confirmed.  
Lymphatic vessels were confirmed underneath the 
DB,  and the point at which the contrast agent flowed 
back from collecting lymphatic vessels to the dermis was 
observed three-dimensionally.  The collecting lymphatic 
vessels under the superficial fascia branched into several 
small lymphatic vessels,  and they traveled to the surface 
of dermis and then connected to the DB (Fig. 4).  
Lymphoscintigraphy and ICG-LG from the same loca-
tion showed that only the DB,  and lymphatic vessels 
underneath the DB were masked and not shown 
(Fig. 5).
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Fig. 1　 Comparison of sites reached by the contrast agent.  Lymphoscintigraphy (light gray bar) provided good imagery up to the thigh in 
almost all cases.  However,  CT-LG (dark gray bar) did not visualize as far as the thigh; in most cases it provided visualization only up to 
the leg.  Only one case was static,  in which the contrast agent was not taken up by lymphatic vessels.
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Fig. 2　 Diameters of lymphatic vessels as observed with CT-LG.  We were able to identity a total of 45 lymphatic vessels,  and the mean 
diameter of the narrowest portion was 1.2 mm.  The smallest lymphatic vessel identiﬁed was 0.7-mm-dia.
Discussion
In the present study,  we used CT-LG,  a method 
widely used for the imaging of sentinel lymph nodes,  in 
patients with lower-extremity lymphedema.  The proto-
col for this study was determined and implemented 
based on the protocol for sentinel lymph node testing.  
For comparison,  we also performed lymphoscintigra-
phy,  the gold-standard examination of the lymphatic 
system,  and ICG-LG,  which has become popular in 
recent years,  for the same patients.
To verify the protocol,  we compared the usefulness 
of CT-LG with that of lymphoscintigraphy in early-stage 
lymphedema patients showing less degeneration of the 
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Fig. 3　 Three-dimensional imaging of lymphatic system.  In the 
images (left: 3D reconstructed image,  right: 1-mm-slice image),  
lymphatic vessels were clearly identiﬁed with higher contrast than 
surrounding tissues,  and the diameters were measured.
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Fig. 4　 Detailed analysis of DB sites with CT-LG.  Slice images 
(a ,1-4) show some collecting lymphatic vessels (arrow) branching 
upward and medially toward the dermis (arrowhead),  transitioning to 
the DB.  In the representative high-contrast 3D image (b),  lym-
phatic vessels were hidden under DB and could not be observed,  
but in the representative lower-contrast 3D image (c),  lymphatic 
vessels that were previously hidden under the DB were observed.  
Panel d is a schematic representation of the DB.  C,  Collector; SLV,  
small lymphatic vessel; D,  dermis; SF,  superﬁcial fat layer; DF,  
deep fat layer; DB (blue area in the dermis),  dermal backﬂow.
Lymphoscintigraphy ICG-lymphography
Fig. 5　 Comparison of lymphoscintigraphy and ICG-LG.  The 
same position as that shown in Fig.3 is compared using lympho-
scintigraphy (left) and ICG-LG (right).  With lymphoscintigraphy,  the 
proximal part is visualized better than with CT-LG but the resolution 
is low and two-dimensional; therefore,  bundles of lymphatic ves-
sels were observed as a lymphatic pathway,  but individual vessels 
could not be observed in detail,  and a detailed observation of DB 
parts could not be made.  DB spread was also detected by ICG-LG,  
and as it is a two-dimensional image,  the three-dimensional struc-
tures deep under the DB cannot be analyzed.
lymphatic system.  With lymphoscintigraphy,  lymphatic 
vessels were well visualized up to the thigh.  With 
CT-LG by the present protocol in same group,  the 
uptake of the contrast agent was limited to the dorsum 
of the foot and the leg,  and the depicting results for the 
thigh were poor.  
Previous reports of the CT-LG protocol for sentinel 
node examination in breast cancer revealed good visu-
alization of the lymphatic vessels [12-15],  and in the 
present study peripheral lymphatic vessels were mostly 
well depicted by CT-LG.  Thus,  there was no problem 
with uptake by lymphatic vessels in CT-LG.  The reason 
for poor visualization of lymphatic vessels at thigh level 
in CT-LG was probably the slower flow of the contrast 
agent in lymphatic vessels,  or alternatively the uptake of 
the contrast agent may be less in the lymphatic system 
compared to the radio-isotope tracer used in lympho-
scintigraphy.  Further improvement in the CT-LG pro-
tocol is needed.  Considering the fact that lymph flows 
centrally over time,  increasing the imaging time to 
30 min or more and increasing the exercise load in 
addition to massaging the injected sites to increase the 
lymphatic flow [9 , 17] may also be helpful.
We anatomically evaluated CT-LG with the well-im-
aged dorsum of the foot and leg.  Lymphatic vessels of 
typical diameter for collecting lymphatics (i.e.,  0.7-
2.1 mm) were observed at high resolution.  In lympho-
scintigraphy,  bundles of lymphatic vessels were 
observed as a lymphatic pathway,  but individual vessels 
could not be observed in detail,  which is a major 
advantage of CT-LG.  In addition,  lymphoscintigraphy 
and ICG-LG are two-dimensional examinations,  and 
thus information from deeper tissues cannot be 
obtained.  Therefore,  CT-LG with its three-dimensional 
observation of deeper tissues provides new informa-
tion.  There are reports of ICG-LG with efficient obser-
vation of DB types and classification,  but such classifi-
cation was not possible with CT-LG.  In other words,  in 
terms of resolution,  CT-LG is inferior to ICG-LG.  This 
could be improved with the development of future CT 
devices.
Though the type of DB could not be confirmed in the 
present study,  the 3D CT-LG images offer fine high 
resolution; we were thus able to confirm images indi-
cating the mechanism of DB.  From collecting lym-
phatic vessels,  several thinner lymphatic vessels branch 
out toward the dermis,  transitioning to the DB.  To the 
best of our knowledge,  we are the first to report 
three-dimensional findings of this anatomy.  The term 
‘DB’ was coined because lymph accumulates in either 
skin or subcutaneous tissues macroscopically and/or 
physically [18],  but it was unknown where lymph 
leaked from and how it flowed back to accumulate in the 
dermis.  According to the information obtained in the 
present investigation,  lymphatic vessels that branch 
from collecting lymphatic vessels toward the dermis 
have an inner diameter wide enough to be confirmed 
with CT.  This was likely the observation of lymph flow-
ing back to new or existing abnormal lymphatic vessels 
as it moves toward the dermis.  From there,  lymph flows 
back through capillary lymphatic vessels,  leading to its 
storage in interstitial spaces (Fig. 4).  It is unclear why 
such a phenomenon occurs there,  but due to upstream 
blockage or increased internal pressure of lymphatic 
vessels,  lymph appears to flow back from deeper areas 
to shallower areas,  as if to escape.  
In the present CT-LG protocol,  imaging at the thigh 
level was poor,  but the resolution of the anatomical 
information on the imaged areas was superior to that 
provided by lymphoscintigraphy,  and the information 
of the deep layer was far better than shown by both 
lymphoscintigraphy and ICG-LG.  These characteristics 
of CT-LG could help to reveal the lymph flow in 
lymph-circulation disorders,  and the anatomical infor-
mation provided by CT-LG would be a great advantage 
to perform conservative or surgical treatment for 
lymphedema patients.  When the location of the DB and 
the developmental mechanism are accurately visualized,  
this information would be valuable when selecting sur-
gical sites in the currently used lymphatico-venous 
anastomosis (LVA) procedure for creating a lymph 
drainage route in lymphedema patients.  
The main limitation of the present study is that CT 
could only be performed once,  to avoid multiple expo-
sures to radiation.  Therefore,  the protocol did not 
allow for the imaging of central body parts.  Thus,  in the 
future,  it is necessary to investigate the optimum timing 
while exploratory adjusting the time from the adminis-
tration of the contrast agent to the imaging of the CT,  
and a protocol suitable for routine examinations should 
be established.  
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